Compare $OVID vs $RZLT | Chartloom

Compare

$OVID vs $RZLT

Ovid Therapeutics Inc · Rezolute Inc

OVID

Ovid Therapeutics Inc

RZLT

Rezolute Inc

Compare $OVID vs $RZLT

Comparing Ovid Therapeutics Inc and Rezolute Inc

OVIDOvid Therapeutics Inc

RZLTRezolute Inc

OVIDOvid Therapeutics Inc

Market cap

$459M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,284.26x

Rev growth (TTM)

-76.2%

YTD performance

39.8%

52W performance

55.7%

FCF yield

-11.9%

RZLTRezolute Inc

Market cap

$469M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

124.9%

52W performance

-44.2%

FCF yield

-13.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OVID

RZLT

Detailed metrics comparison

OVID

Ovid Therapeutics Inc

RZLT

Rezolute Inc

Market Cap

OVID$459M

RZLT$469M

Enterprise Value

OVID$448M

RZLT$458M

Price

OVID$2.46

RZLT$4.87

P/E Ratio

OVIDN/A

RZLTN/A

P/S Ratio

OVID290.04x

RZLT0.00x

EV/Sales

OVID282.89x

RZLT0.00x

EV/EBITDA

OVID3.65x

RZLT0.00x

P/B Ratio

OVID2.21x

RZLT3.85x

P/FCF Ratio

OVIDN/A

RZLTN/A

EV/FCF

OVID-8.18x

RZLT-7.09x

PEG Ratio

OVIDN/A

RZLTN/A

Forward P/E (NTM)

OVIDN/A

RZLTN/A

Forward P/S (NTM)

OVID1,284.26x

RZLTN/A

Revenue (TTM)

OVID$2M

RZLT$0

Revenue Growth (YoY)

OVID-76.2%

RZLTN/A

Forward Rev Growth

OVID-72.6%

RZLT2194.8%

Gross Margin (TTM)

OVID0.0%

RZLT0.0%

Operating Margin (TTM)

OVID0.0%

RZLT0.0%

EBITDA Margin (TTM)

OVID-3681.4%

RZLT0.0%

Net Margin (TTM)

OVID-2178.9%

RZLT0.0%

FCF Margin (TTM)

OVID-3460.1%

RZLTN/A

Net Income (TTM)

OVID$-34M

RZLT$-78M

FCF (TTM)

OVID$-55M

RZLT$-65M

EPS (TTM)

OVID-$0.17

RZLT-$0.74

ROE (TTM)

OVID-2364.0%

RZLT-6299.0%

ROA (TTM)

OVID-2052.0%

RZLT-5794.0%

ROIC (TTM)

OVID-2364.0%

RZLT-6299.0%

Cash

OVID$11M

RZLT$11M

Debt

OVID$0

RZLT$0

Net Cash/Debt

OVID$11M

RZLT$11M

Current Ratio (TTM)

OVID12.39x

RZLT9.68x

Quick Ratio (TTM)

OVID11.75x

RZLT9.44x

Debt/Equity (TTM)

OVID0.00x

RZLT0.00x

Debt/Assets (TTM)

OVID0.0%

RZLT0.0%

Interest Coverage (TTM)

OVIDN/A

RZLTN/A

Net Debt/EBITDA (TTM)

OVID0.00x

RZLT0.00x

Beta

OVID0.28

RZLT0.58

52W Performance

OVID55.7%

RZLT-44.2%

YTD Performance

OVID39.8%

RZLT124.9%

% from 52W High

OVID-20.8%

RZLT-57.5%

% from 52W Low

OVID108.5%

RZLT355.1%

Asset Turnover (TTM)

OVID0.01x

RZLT0.00x

FCF Yield (TTM)

OVID-11.9%

RZLT-13.8%

Earnings Yield (TTM)

OVID-7.5%

RZLT-16.5%

Dividend Yield (TTM)

OVIDN/A

RZLTN/A

Rule of 40

OVID-3,536.3

RZLT0.0

EV/GP/RG

OVIDN/A

RZLTN/A

Ticker research

View OVID research View RZLT research

Metric	OVID Ovid Therapeutics Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$459M	$469M
Enterprise Value	$448M	$458M
Price	$2.46	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	290.04x	0.00x
EV/Sales	282.89x	0.00x
EV/EBITDA	3.65x	0.00x
P/B Ratio	2.21x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.18x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,284.26x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-76.2%	N/A
Forward Rev Growth	-72.6%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3681.4%	0.0%
Net Margin (TTM)	-2178.9%	0.0%
FCF Margin (TTM)	-3460.1%	N/A
Net Income (TTM)	$-34M	$-78M
FCF (TTM)	$-55M	$-65M
EPS (TTM)	-$0.17	-$0.74
ROE (TTM)	-2364.0%	-6299.0%
ROA (TTM)	-2052.0%	-5794.0%
ROIC (TTM)	-2364.0%	-6299.0%
Financial Health
Cash	$11M	$11M
Debt	$0	$0
Net Cash/Debt	$11M	$11M
Current Ratio (TTM)	12.39x	9.68x
Quick Ratio (TTM)	11.75x	9.44x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.28	0.58
52W Performance	55.7%	-44.2%
YTD Performance	39.8%	124.9%
% from 52W High	-20.8%	-57.5%
% from 52W Low	108.5%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-11.9%	-13.8%
Earnings Yield (TTM)	-7.5%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,536.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OVID research	View RZLT research

Valuation

P/S Ratio

RZLT

0.00x

OVID

290.04x

EV/FCF

OVID

-8.18x

RZLT

-7.09x

Growth & revenue

Revenue Growth TTM

OVID

-76.2%

Forward Revenue Growth

RZLT

2194.8%

OVID

-72.6%

Profitability & performance

Gross Margin

OVID

0.0%

RZLT

0.0%

ROE

OVID

-2364.0%

RZLT

-6299.0%

FCF Yield %

OVID

-11.9%

RZLT

-13.8%

52-Week Performance

OVID

55.7%

RZLT

-44.2%

Detailed metrics comparison

OVID

Ovid Therapeutics Inc

RZLT

Rezolute Inc

Market Cap

OVID$459M

RZLT$469M

Enterprise Value

OVID$448M

RZLT$458M

Price

OVID$2.46

RZLT$4.87

P/E Ratio

OVIDN/A

RZLTN/A

P/S Ratio

OVID290.04x

RZLT0.00x

EV/Sales

OVID282.89x

RZLT0.00x

EV/EBITDA

OVID3.65x

RZLT0.00x

P/B Ratio

OVID2.21x

RZLT3.85x

P/FCF Ratio

OVIDN/A

RZLTN/A

EV/FCF

OVID-8.18x

RZLT-7.09x

PEG Ratio

OVIDN/A

RZLTN/A

Forward P/E (NTM)

OVIDN/A

RZLTN/A

Forward P/S (NTM)

OVID1,284.26x

RZLTN/A

Revenue (TTM)

OVID$2M

RZLT$0

Revenue Growth (YoY)

OVID-76.2%

RZLTN/A

Forward Rev Growth

OVID-72.6%

RZLT2194.8%

Gross Margin (TTM)

OVID0.0%

RZLT0.0%

Operating Margin (TTM)

OVID0.0%

RZLT0.0%

EBITDA Margin (TTM)

OVID-3681.4%

RZLT0.0%

Net Margin (TTM)

OVID-2178.9%

RZLT0.0%

FCF Margin (TTM)

OVID-3460.1%

RZLTN/A

Net Income (TTM)

OVID$-34M

RZLT$-78M

FCF (TTM)

OVID$-55M

RZLT$-65M

EPS (TTM)

OVID-$0.17

RZLT-$0.74

ROE (TTM)

OVID-2364.0%

RZLT-6299.0%

ROA (TTM)

OVID-2052.0%

RZLT-5794.0%

ROIC (TTM)

OVID-2364.0%

RZLT-6299.0%

Cash

OVID$11M

RZLT$11M

Debt

OVID$0

RZLT$0

Net Cash/Debt

OVID$11M

RZLT$11M

Current Ratio (TTM)

OVID12.39x

RZLT9.68x

Quick Ratio (TTM)

OVID11.75x

RZLT9.44x

Debt/Equity (TTM)

OVID0.00x

RZLT0.00x

Debt/Assets (TTM)

OVID0.0%

RZLT0.0%

Interest Coverage (TTM)

OVIDN/A

RZLTN/A

Net Debt/EBITDA (TTM)

OVID0.00x

RZLT0.00x

Beta

OVID0.28

RZLT0.58

52W Performance

OVID55.7%

RZLT-44.2%

YTD Performance

OVID39.8%

RZLT124.9%

% from 52W High

OVID-20.8%

RZLT-57.5%

% from 52W Low

OVID108.5%

RZLT355.1%

Asset Turnover (TTM)

OVID0.01x

RZLT0.00x

FCF Yield (TTM)

OVID-11.9%

RZLT-13.8%

Earnings Yield (TTM)

OVID-7.5%

RZLT-16.5%

Dividend Yield (TTM)

OVIDN/A

RZLTN/A

Rule of 40

OVID-3,536.3

RZLT0.0

EV/GP/RG

OVIDN/A

RZLTN/A

Ticker research

View OVID research View RZLT research

Metric	OVID Ovid Therapeutics Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$459M	$469M
Enterprise Value	$448M	$458M
Price	$2.46	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	290.04x	0.00x
EV/Sales	282.89x	0.00x
EV/EBITDA	3.65x	0.00x
P/B Ratio	2.21x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.18x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,284.26x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-76.2%	N/A
Forward Rev Growth	-72.6%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3681.4%	0.0%
Net Margin (TTM)	-2178.9%	0.0%
FCF Margin (TTM)	-3460.1%	N/A
Net Income (TTM)	$-34M	$-78M
FCF (TTM)	$-55M	$-65M
EPS (TTM)	-$0.17	-$0.74
ROE (TTM)	-2364.0%	-6299.0%
ROA (TTM)	-2052.0%	-5794.0%
ROIC (TTM)	-2364.0%	-6299.0%
Financial Health
Cash	$11M	$11M
Debt	$0	$0
Net Cash/Debt	$11M	$11M
Current Ratio (TTM)	12.39x	9.68x
Quick Ratio (TTM)	11.75x	9.44x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.28	0.58
52W Performance	55.7%	-44.2%
YTD Performance	39.8%	124.9%
% from 52W High	-20.8%	-57.5%
% from 52W Low	108.5%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-11.9%	-13.8%
Earnings Yield (TTM)	-7.5%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,536.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OVID research	View RZLT research